MedPath

Concentrated exposure treatment of obsessive-compulsive disorder: The Bergen 4-Day OCD Treatment (B4DT)

Not Applicable
Recruiting
Conditions
F42
Obsessive-compulsive disorder
Registration Number
DRKS00030022
Lead Sponsor
niversitätsklinikum Hamburg-Eppendorf
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
25
Inclusion Criteria

Diagnosed with obsessive-compulsive disorder (ICD-10: F 42)
18 to 75 years of age
Willingness and consent to participate in the study (informed consent)
Stable pharmacological treatment before treatment start

Exclusion Criteria

Acute suicidality
Psychotic symptoms
Substance dependence

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome parameter is the change in obsessive-compulsive symptomatology, assessed with the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) from t0 to t1 and after the two follow-ups (t2 and t3). Response and remission will also be calculated using the Y-BOCS.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath